Analysis of samples from patients with WBS and their progenitors with block B SSNs to map deletion breakpoints. Relative block dosages calculated from band intensities, as described in the “Methods” section, are depicted bellow each lane. a, Representative results of the SSN 4 assay, which amplifies exon 2 of the NCF1 gene and NCF1P1/NCF1P2 pseudogenes. Both pseudogenes in blocks Bc and Bt have a 2-bp deletion at the beginning of exon 2 (delGT) that is not present in the NCF1 gene in Bm. Patients 20.01 and 21.01 show one gene copy versus four pseudogenes, suggesting that the deletion breakpoint is telomeric to this point. Patients 3.01 and 61.01 display two gene copies versus three pseudogenes, indicating that the crossing-over occurred proximal to this position. Patients 17.01 and 35.01 have a 1 Bm:4 (Bc+Bt) ratio, most likely because of the presence of three block Bt copies (see fig. 3c). Progenitor 21.12 has three gene-type copies and three pseudogenes, most probably as a result of gene conversion. b, Results of the SSN 9 assay in a few patients. A nucleotide change in exon 14 of GTF2RD2/GTF2RD2P1/GTF2RD2P2 creates a restriction site for HaeIII in blocks Bm and Bt that is not present in Bc, as represented in the scheme. Patients 20.01 and 40.01 show three digested copies versus two nondigested copies, indicating that unequal crossing-over occurred distal to this position. On the contrary, patients 71.01 and 37.01 have three digested copies versus two nondigested copies, showing that the breakpoint is proximal to this nucleotide. Patients 17.01 and 35.01 display a 1 Bc:4 (Bc+Bt) ratio, most likely because of the presence of three block Bt copies (see panel c). c, SSN 11 assay allows detection of the inversion in patients with WBS. As represented in the scheme, a nucleotide change in block Bt destroys a Tru9I site that is present in blocks Bc and Bm. Patients 7.01, 71.01, and 42.01 show three digested copies (blocks Bc and Bm) versus two nondigested copies (block Bt), suggesting the existence of two block Bt copies, one in each chromosome. In patients 17.01 and 35.01, we observe a reduction of the intensity of bands 3 and 4 (Bc and Bm) and an increase of the intensity of band 1 (Bt). The patient/progenitor block B ratio is close to 3 in both cases, suggesting the existence of three block Bt copies (one in the normal chromosome and two in the WBS chromosome) but only two blocks Bc and Bm (both in the normal chromosome). The 3 Bt:2 (Bc+Bm) ratio suggests that the WBS chromosome arose in a progenitor heterozygous for the inversion. Dosage calculations in sample 23.11 indicate that he has only one Bt-like copy versus five Bc and Bm blocks, most probably as a result of gene conversion. His son, patient 23.01, inherited this polymorphism.